Special Issue "Cardiothoracic Surgery: State of the Art and Future Perspectives - Part II"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "General Surgery".

Deadline for manuscript submissions: 31 October 2023 | Viewed by 1660

Special Issue Editor

1. Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Suite 715, Shadyside Medical Building, 5200 Centre Avenue, Pittsburgh, PA 15232, USA
2. VA Pittsburgh Healthcare System, University Drive C, Pittsburgh, PA 15240, USA
Interests: thoracic cancers; lung cancer immunotherapy; malignant pleural effusions; radiomics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cardiothoracic surgery deals with some of the most important disease states faced by humanity. The efforts to improve the longevity for those who suffer from coronary artery disease, aortic aneurysms, lung failure, lung cancer, and esophageal cancer have given surgeons the opportunity to be on the cutting edge of our greatest medical advances. The last three decades have seen the introduction and adoption of minimally invasive techniques, robotic-assisted procedures, artificial-intelligence-assisted diagnostics, immunotherapeutic treatments, and biomarker-based risk assessment, among others. The rate of advance is staggering, and the next decade will likely usher in the ability to drastically improve our diagnostic and therapeutic capabilities. This Special Issue of the Journal of Clinical Medicine, “Cardiothoracic Surgery: State of the Art and Future Perspectives – Part II”, highlights the most recent advances in the field as related to the diagnosis and treatment of disease states faced by cardiothoracic surgeons.

Dr. Rajeev Dhupar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiothoracic surgery advances
  • minimally invasive surgery
  • artificial intelligence
  • immunotherapy in thoracic cancers
  • lung transplant
  • esophageal cancer
  • lung cancer
  • aortic aneurysm

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Lung Transplantation Outcomes in Recipients Aged 70 Years or Older and the Impact of Center Volume
J. Clin. Med. 2023, 12(16), 5372; https://doi.org/10.3390/jcm12165372 - 18 Aug 2023
Viewed by 321
Abstract
Objective: To evaluate trends and outcomes of lung transplants (LTx) in recipients ≥ 70 years. Methods: We performed a retrospective analysis of the UNOS database identifying all patients undergoing LTx (May 2005–December 2022). Baseline characteristics and postoperative outcomes were compared by age (<70 [...] Read more.
Objective: To evaluate trends and outcomes of lung transplants (LTx) in recipients ≥ 70 years. Methods: We performed a retrospective analysis of the UNOS database identifying all patients undergoing LTx (May 2005–December 2022). Baseline characteristics and postoperative outcomes were compared by age (<70 years, ≥70 years) and center volume. Kaplan–Meier analyses were performed with pairwise comparisons between subgroups. Results: 34,957 patients underwent LTx, of which 3236 (9.3%) were ≥70 years. The rate of LTx in recipients ≥ 70 has increased over time, particularly in low-volume centers (LVCs); consequently, high-volume centers (HVCs) and LVCs perform similar rates of LTx for recipients ≥ 70. Recipients ≥ 70 had higher rates of receiving from donor after circulatory death lungs and of extended donor criteria. Recipients ≥ 70 were more likely to die of cardiovascular diseases or malignancy, while recipients < 70 of chronic primary graft failure. Survival time was shorter for recipients ≥ 70 compared to recipients < 70 old (hazard ratio (HR): 1.36, 95% confidence interval (CI): 1.28–1.44, p < 0.001). HVCs were associated with a survival advantage in recipients < 70 (HR: 0.91, 95% CI: 0.88–0.94, p < 0.001); however, in recipients ≥ 70, survival was similar between HVCs and LVCs (HR: 1.11, 95% CI: 0.99–1.25, p < 0.08). HVCs were more likely to perform a bilateral LTx (BLT) for obstructive lung diseases compared to LVCs, but there was no difference in BLT and single LTx likelihood for restrictive lung diseases. Conclusions: Careful consideration is needed for recipient ≥ 70 selection, donor assessment, and post-transplant care to improve outcomes. Further research should explore strategies that advance perioperative care in centers with low long-term survival for recipients ≥ 70. Full article
Show Figures

Figure 1

Article
CT-Derived Body Composition Is a Predictor of Survival after Esophagectomy
J. Clin. Med. 2023, 12(6), 2106; https://doi.org/10.3390/jcm12062106 - 08 Mar 2023
Cited by 1 | Viewed by 1103
Abstract
Background: Body composition can be accurately quantified based on computed tomography (CT) and typically reflects an individual’s overall health status. However, there is a dearth of research examining the relationship between body composition and survival following esophagectomy. Methods: We created a cohort consisting [...] Read more.
Background: Body composition can be accurately quantified based on computed tomography (CT) and typically reflects an individual’s overall health status. However, there is a dearth of research examining the relationship between body composition and survival following esophagectomy. Methods: We created a cohort consisting of 183 patients who underwent esophagectomy for esophageal cancer without neoadjuvant therapy. The cohort included preoperative PET-CT scans, along with pathologic and clinical data, which were collected prospectively. Radiomic, tumor, PET, and body composition features were automatically extracted from the images. Cox regression models were utilized to identify variables associated with survival. Logistic regression and machine learning models were developed to predict one-, three-, and five-year survival rates. Model performance was evaluated based on the area under the receiver operating characteristics curve (ROC/AUC). To test for the statistical significance of the impact of body composition on survival, body composition features were excluded for the best-performing models, and the DeLong test was used. Results: The one-year survival model contained 10 variables, including three body composition variables (bone mass, bone density, and visceral adipose tissue (VAT) density), and demonstrated an AUC of 0.817 (95% CI: 0.738–0.897). The three-year survival model incorporated 14 variables, including three body composition variables (intermuscular adipose tissue (IMAT) volume, IMAT mass, and bone mass), with an AUC of 0.693 (95% CI: 0.594–0.792). For the five-year survival model, 10 variables were included, of which two were body composition variables (intramuscular adipose tissue (IMAT) volume and visceral adipose tissue (VAT) mass), with an AUC of 0.861 (95% CI: 0.783–0.938). The one- and five-year survival models exhibited significantly inferior performance when body composition features were not incorporated. Conclusions: Body composition features derived from preoperative CT scans should be considered when predicting survival following esophagectomy. Full article
Show Figures

Figure 1

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

"To be or not to be- In the trail of the hypothetical lower shunt fraction during non intubated surgery"
 
Back to TopTop